2.27 USD
↗ 0.57 (33.53%)AT CLOSE (11:59 AM EDT)
Chemomab Therapeutics Ltd. American Depositary Share
CMMBNASDAQ • USD
2.32
↗ 0.05 (2.20%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.32
↗ 0.05 (2.20%)
Market: CLOSED
CMMB is currently priced at $2.27. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 2, 2026.
Open?$1.75
High?$2.42
Low?$1.75
Prev. Close?$1.70
Volume?1.4M
Avg. Volume?92.4K
VWAP?$2.21
Rel. Volume?15.08x
Bid / Ask
Bid?$2.27 × 400
Ask?$2.36 × 500
Spread?$0.09
Midpoint?$2.32
Valuation & Ratios
Market Cap?16.3M
Shares Out?7.2M
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$4.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Employees
12
Market Cap
16.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-03-17
Address
KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.80Distress
Confidence?44%Low
Short InterestLow
Short Interest?134.3K
Days to Cover?2.7
Avg Daily Volume49.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.82Strong
Quick Ratio?4.82Strong
Cash Ratio?2.97Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.58CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-111.9%WEAK▾
S&P3
ROA?-89.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-23900000
Enterprise Value?$-4420142
Fundamentals ratios updated end of day